APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Biomedical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence in Biomedical Market Outlook and Growth Opportunities 2026

3 July 2026215 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Biomedical Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Biomedical Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Biomedical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Biomedical Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Biomedical Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Biomedical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence in Biomedical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence in Biomedical market include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence in Biomedical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence in Biomedical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence in Biomedical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence in Biomedical market.

Artificial Intelligence in Biomedical Segment by Company

AstraZeneca

Thales Group

IBM Corp.

ForeSee Medical

Atomwise

Cloud Pharmaceuticals

GNS Healthcare

Microsoft Corporation

Novartis AG

NVIDIA Corporation

Pfizer

Recursion Pharmaceuticals

XtalPi Inc

Aidoc

AliveCor

GE Healthcare

Imagen Technologies

Vuno Inc.

IDx Technologies Inc.

Siemens Healthcare GmbH

Neural Analytics

Artificial Intelligence in Biomedical Segment by Type

Hardware

Software

Artificial Intelligence in Biomedical Segment by Application

Diagnosing Diseases

Developing Drugs

Personalized Treatment

Other

Artificial Intelligence in Biomedical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence in Biomedical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence in Biomedical key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence in Biomedical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence in Biomedical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence in Biomedical significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence in Biomedical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Biomedical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Biomedical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Biomedical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence in Biomedical industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Biomedical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence in Biomedical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence in Biomedical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence in Biomedical Industry Trends Table 2. Artificial Intelligence in Biomedical Industry Drivers Table 3. Artificial Intelligence in Biomedical Industry Opportunities and Challenges Table 4. Artificial Intelligence in Biomedical Industry Restraints Table 5. Global Artificial Intelligence in Biomedical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence in Biomedical Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence in Biomedical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence in Biomedical Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence in Biomedical Company, Product Type & Application Table 10. Global Artificial Intelligence in Biomedical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence in Biomedical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Table 15. Significant Companies of Software Table 16. Global Artificial Intelligence in Biomedical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Artificial Intelligence in Biomedical Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Artificial Intelligence in Biomedical Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Artificial Intelligence in Biomedical Sales Value Share by Type (2021-2026) Table 20. Global Artificial Intelligence in Biomedical Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diagnosing Diseases Table 22. Significant Companies of Developing Drugs Table 23. Significant Companies of Personalized Treatment Table 24. Significant Companies of Other Table 25. Global Artificial Intelligence in Biomedical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artificial Intelligence in Biomedical Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Artificial Intelligence in Biomedical Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Artificial Intelligence in Biomedical Sales Value Share by Application (2021-2026) Table 29. Global Artificial Intelligence in Biomedical Sales Value Share by Application (2027-2032) Table 30. Global Artificial Intelligence in Biomedical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Artificial Intelligence in Biomedical Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Artificial Intelligence in Biomedical Sales Value Share by Region (2021-2026) Table 33. Global Artificial Intelligence in Biomedical Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence in Biomedical Sales Value Share by Region (2027-2032) Table 35. Global Artificial Intelligence in Biomedical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Artificial Intelligence in Biomedical Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Artificial Intelligence in Biomedical Sales Value Market Share by Country (2021-2026) Table 38. Global Artificial Intelligence in Biomedical Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Artificial Intelligence in Biomedical Sales Value Market Share by Country (2027-2032) Table 40. AstraZeneca Company Information Table 41. AstraZeneca Business Overview Table 42. AstraZeneca Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. AstraZeneca Artificial Intelligence in Biomedical Product Portfolio Table 44. AstraZeneca Recent Development Table 45. Thales Group Company Information Table 46. Thales Group Business Overview Table 47. Thales Group Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Thales Group Artificial Intelligence in Biomedical Product Portfolio Table 49. Thales Group Recent Development Table 50. IBM Corp. Company Information Table 51. IBM Corp. Business Overview Table 52. IBM Corp. Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. IBM Corp. Artificial Intelligence in Biomedical Product Portfolio Table 54. IBM Corp. Recent Development Table 55. ForeSee Medical Company Information Table 56. ForeSee Medical Business Overview Table 57. ForeSee Medical Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio Table 59. ForeSee Medical Recent Development Table 60. Atomwise Company Information Table 61. Atomwise Business Overview Table 62. Atomwise Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Atomwise Artificial Intelligence in Biomedical Product Portfolio Table 64. Atomwise Recent Development Table 65. Cloud Pharmaceuticals Company Information Table 66. Cloud Pharmaceuticals Business Overview Table 67. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 69. Cloud Pharmaceuticals Recent Development Table 70. GNS Healthcare Company Information Table 71. GNS Healthcare Business Overview Table 72. GNS Healthcare Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 74. GNS Healthcare Recent Development Table 75. Microsoft Corporation Company Information Table 76. Microsoft Corporation Business Overview Table 77. Microsoft Corporation Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio Table 79. Microsoft Corporation Recent Development Table 80. Novartis AG Company Information Table 81. Novartis AG Business Overview Table 82. Novartis AG Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Novartis AG Artificial Intelligence in Biomedical Product Portfolio Table 84. Novartis AG Recent Development Table 85. NVIDIA Corporation Company Information Table 86. NVIDIA Corporation Business Overview Table 87. NVIDIA Corporation Artificial Intelligence in Biomedical Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio Table 89. NVIDIA Corporation Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Pfizer Artificial Intelligence in Biomedical Product Portfolio Table 94. Pfizer Recent Development Table 95. Recursion Pharmaceuticals Company Information Table 96. Recursion Pharmaceuticals Business Overview Table 97. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 99. Recursion Pharmaceuticals Recent Development Table 100. XtalPi Inc Company Information Table 101. XtalPi Inc Business Overview Table 102. XtalPi Inc Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio Table 104. XtalPi Inc Recent Development Table 105. Aidoc Company Information Table 106. Aidoc Business Overview Table 107. Aidoc Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Aidoc Artificial Intelligence in Biomedical Product Portfolio Table 109. Aidoc Recent Development Table 110. AliveCor Company Information Table 111. AliveCor Business Overview Table 112. AliveCor Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. AliveCor Artificial Intelligence in Biomedical Product Portfolio Table 114. AliveCor Recent Development Table 115. GE Healthcare Company Information Table 116. GE Healthcare Business Overview Table 117. GE Healthcare Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. GE Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 119. GE Healthcare Recent Development Table 120. Imagen Technologies Company Information Table 121. Imagen Technologies Business Overview Table 122. Imagen Technologies Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio Table 124. Imagen Technologies Recent Development Table 125. Vuno Inc. Company Information Table 126. Vuno Inc. Business Overview Table 127. Vuno Inc. Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio Table 129. Vuno Inc. Recent Development Table 130. IDx Technologies Inc. Company Information Table 131. IDx Technologies Inc. Business Overview Table 132. IDx Technologies Inc. Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio Table 134. IDx Technologies Inc. Recent Development Table 135. Siemens Healthcare GmbH Company Information Table 136. Siemens Healthcare GmbH Business Overview Table 137. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio Table 139. Siemens Healthcare GmbH Recent Development Table 140. Neural Analytics Company Information Table 141. Neural Analytics Business Overview Table 142. Neural Analytics Artificial Intelligence in Biomedical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Neural Analytics Artificial Intelligence in Biomedical Product Portfolio Table 144. Neural Analytics Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Artificial Intelligence in Biomedical Product Image Figure 2. Global Artificial Intelligence in Biomedical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence in Biomedical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Image Figure 8. Software Image Figure 9. Global Artificial Intelligence in Biomedical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artificial Intelligence in Biomedical Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Artificial Intelligence in Biomedical Sales Value Share by Type (2021-2032) Figure 12. Diagnosing Diseases Image Figure 13. Developing Drugs Image Figure 14. Personalized Treatment Image Figure 15. Other Image Figure 16. Global Artificial Intelligence in Biomedical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artificial Intelligence in Biomedical Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence in Biomedical Sales Value Share by Application (2021-2032) Figure 19. Global Artificial Intelligence in Biomedical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Artificial Intelligence in Biomedical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Artificial Intelligence in Biomedical Sales Value (2021-2032) & (US$ Million) Figure 22. North America Artificial Intelligence in Biomedical Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Artificial Intelligence in Biomedical Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Artificial Intelligence in Biomedical Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Artificial Intelligence in Biomedical Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Artificial Intelligence in Biomedical Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Artificial Intelligence in Biomedical Sales Value (2021-2032) & (US$ Million) Figure 28. South America Artificial Intelligence in Biomedical Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Artificial Intelligence in Biomedical Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Artificial Intelligence in Biomedical Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Diagnosing Diseases
  • Developing Drugs
  • Personalized Treatment
  • Other
Companies covered
  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence in Biomedical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence in Biomedical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Biomedical Market Dynamics
  1. 2.1 Artificial Intelligence in Biomedical Industry Trends
  2. 2.2 Artificial Intelligence in Biomedical Industry Drivers
  3. 2.3 Artificial Intelligence in Biomedical Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Biomedical Industry Restraints
3 Artificial Intelligence in Biomedical Market by Company
  1. 3.1 Global Artificial Intelligence in Biomedical Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence in Biomedical Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence in Biomedical Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence in Biomedical Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence in Biomedical Company Product Type and Application
  6. 3.6 Global Artificial Intelligence in Biomedical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence in Biomedical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence in Biomedical Market by Type
  1. 4.1 Artificial Intelligence in Biomedical Type Introduction
  2. 4.1.1 Hardware
  3. 4.1.2 Software
  4. 4.2 Global Artificial Intelligence in Biomedical Sales Value by Type
  5. 4.2.1 Global Artificial Intelligence in Biomedical Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Intelligence in Biomedical Sales Value by Type (2021-2032)
  7. 4.2.3 Global Artificial Intelligence in Biomedical Sales Value Share by Type (2021-2032)
5 Artificial Intelligence in Biomedical Market by Application
  1. 5.1 Artificial Intelligence in Biomedical Application Introduction
  2. 5.1.1 Diagnosing Diseases
  3. 5.1.2 Developing Drugs
  4. 5.1.3 Personalized Treatment
  5. 5.1.4 Other
  6. 5.2 Global Artificial Intelligence in Biomedical Sales Value by Application
  7. 5.2.1 Global Artificial Intelligence in Biomedical Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artificial Intelligence in Biomedical Sales Value by Application (2021-2032)
  9. 5.2.3 Global Artificial Intelligence in Biomedical Sales Value Share by Application (2021-2032)
6 Artificial Intelligence in Biomedical Regional Value Analysis
  1. 6.1 Global Artificial Intelligence in Biomedical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence in Biomedical Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence in Biomedical Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence in Biomedical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence in Biomedical Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence in Biomedical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence in Biomedical Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence in Biomedical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence in Biomedical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence in Biomedical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence in Biomedical Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence in Biomedical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence in Biomedical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence in Biomedical Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence in Biomedical Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence in Biomedical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence in Biomedical Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence in Biomedical Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence in Biomedical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence in Biomedical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence in Biomedical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence in Biomedical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Artificial Intelligence in Biomedical Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Thales Group
  8. 8.2.1 Thales Group Company Information
  9. 8.2.2 Thales Group Business Overview
  10. 8.2.3 Thales Group Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thales Group Artificial Intelligence in Biomedical Product Portfolio
  12. 8.2.5 Thales Group Recent Developments
  13. 8.3 IBM Corp.
  14. 8.3.1 IBM Corp. Company Information
  15. 8.3.2 IBM Corp. Business Overview
  16. 8.3.3 IBM Corp. Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IBM Corp. Artificial Intelligence in Biomedical Product Portfolio
  18. 8.3.5 IBM Corp. Recent Developments
  19. 8.4 ForeSee Medical
  20. 8.4.1 ForeSee Medical Company Information
  21. 8.4.2 ForeSee Medical Business Overview
  22. 8.4.3 ForeSee Medical Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio
  24. 8.4.5 ForeSee Medical Recent Developments
  25. 8.5 Atomwise
  26. 8.5.1 Atomwise Company Information
  27. 8.5.2 Atomwise Business Overview
  28. 8.5.3 Atomwise Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Atomwise Artificial Intelligence in Biomedical Product Portfolio
  30. 8.5.5 Atomwise Recent Developments
  31. 8.6 Cloud Pharmaceuticals
  32. 8.6.1 Cloud Pharmaceuticals Company Information
  33. 8.6.2 Cloud Pharmaceuticals Business Overview
  34. 8.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  36. 8.6.5 Cloud Pharmaceuticals Recent Developments
  37. 8.7 GNS Healthcare
  38. 8.7.1 GNS Healthcare Company Information
  39. 8.7.2 GNS Healthcare Business Overview
  40. 8.7.3 GNS Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio
  42. 8.7.5 GNS Healthcare Recent Developments
  43. 8.8 Microsoft Corporation
  44. 8.8.1 Microsoft Corporation Company Information
  45. 8.8.2 Microsoft Corporation Business Overview
  46. 8.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio
  48. 8.8.5 Microsoft Corporation Recent Developments
  49. 8.9 Novartis AG
  50. 8.9.1 Novartis AG Company Information
  51. 8.9.2 Novartis AG Business Overview
  52. 8.9.3 Novartis AG Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis AG Artificial Intelligence in Biomedical Product Portfolio
  54. 8.9.5 Novartis AG Recent Developments
  55. 8.10 NVIDIA Corporation
  56. 8.10.1 NVIDIA Corporation Company Information
  57. 8.10.2 NVIDIA Corporation Business Overview
  58. 8.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio
  60. 8.10.5 NVIDIA Corporation Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Artificial Intelligence in Biomedical Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Recursion Pharmaceuticals
  68. 8.12.1 Recursion Pharmaceuticals Company Information
  69. 8.12.2 Recursion Pharmaceuticals Business Overview
  70. 8.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  72. 8.12.5 Recursion Pharmaceuticals Recent Developments
  73. 8.13 XtalPi Inc
  74. 8.13.1 XtalPi Inc Company Information
  75. 8.13.2 XtalPi Inc Business Overview
  76. 8.13.3 XtalPi Inc Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio
  78. 8.13.5 XtalPi Inc Recent Developments
  79. 8.14 Aidoc
  80. 8.14.1 Aidoc Company Information
  81. 8.14.2 Aidoc Business Overview
  82. 8.14.3 Aidoc Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aidoc Artificial Intelligence in Biomedical Product Portfolio
  84. 8.14.5 Aidoc Recent Developments
  85. 8.15 AliveCor
  86. 8.15.1 AliveCor Company Information
  87. 8.15.2 AliveCor Business Overview
  88. 8.15.3 AliveCor Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AliveCor Artificial Intelligence in Biomedical Product Portfolio
  90. 8.15.5 AliveCor Recent Developments
  91. 8.16 GE Healthcare
  92. 8.16.1 GE Healthcare Company Information
  93. 8.16.2 GE Healthcare Business Overview
  94. 8.16.3 GE Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  95. 8.16.4 GE Healthcare Artificial Intelligence in Biomedical Product Portfolio
  96. 8.16.5 GE Healthcare Recent Developments
  97. 8.17 Imagen Technologies
  98. 8.17.1 Imagen Technologies Company Information
  99. 8.17.2 Imagen Technologies Business Overview
  100. 8.17.3 Imagen Technologies Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio
  102. 8.17.5 Imagen Technologies Recent Developments
  103. 8.18 Vuno Inc.
  104. 8.18.1 Vuno Inc. Company Information
  105. 8.18.2 Vuno Inc. Business Overview
  106. 8.18.3 Vuno Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio
  108. 8.18.5 Vuno Inc. Recent Developments
  109. 8.19 IDx Technologies Inc.
  110. 8.19.1 IDx Technologies Inc. Company Information
  111. 8.19.2 IDx Technologies Inc. Business Overview
  112. 8.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  113. 8.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio
  114. 8.19.5 IDx Technologies Inc. Recent Developments
  115. 8.20 Siemens Healthcare GmbH
  116. 8.20.1 Siemens Healthcare GmbH Company Information
  117. 8.20.2 Siemens Healthcare GmbH Business Overview
  118. 8.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio
  120. 8.20.5 Siemens Healthcare GmbH Recent Developments
  121. 8.21 Neural Analytics
  122. 8.21.1 Neural Analytics Company Information
  123. 8.21.2 Neural Analytics Business Overview
  124. 8.21.3 Neural Analytics Artificial Intelligence in Biomedical Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Neural Analytics Artificial Intelligence in Biomedical Product Portfolio
  126. 8.21.5 Neural Analytics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst